This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Morgan Stanley Reaffirms Their Buy Rating on NOV (NOV)
In a report released yesterday, Daniel Kutz from Morgan Stanley maintained a Buy rating on NOV, with a price target of $15.00. The company’s shares closed yesterday at $12.66.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kutz covers the Energy sector, focusing on stocks such as Halliburton, Baker Hughes Company, and Patterson-UTI. According to TipRanks, Kutz has an average return of 4.7% and a 52.00% success rate on recommended stocks.
In addition to Morgan Stanley, NOV also received a Buy from Bank of America Securities’s Saurabh Pant in a report issued on October 14. However, on October 11, TR | OpenAI – 4o downgraded NOV (NYSE: NOV) to a Hold.
The company has a one-year high of $16.86 and a one-year low of $10.84. Currently, NOV has an average volume of 3.7M.
Read More on NOV:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
